First-line drug selection versus sequential treatment in advanced pancreatic cancer: Does it really matter? Multi-institutional Canadian perspective.

Ivan Barrera, Petr Kavan, Jill J. Ranger et al.|Journal of Clinical Oncology|2020

Cited by 0